Drug Interactions between Eliquis and polyethylene glycol 3350 with electrolytes
This report displays the potential drug interactions for the following 2 drugs:
- Eliquis (apixaban)
- polyethylene glycol 3350 with electrolytes
Interactions between your drugs
No interactions were found between Eliquis and polyethylene glycol 3350 with electrolytes. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Eliquis
A total of 395 drugs are known to interact with Eliquis.
- Eliquis is in the drug class factor Xa inhibitors.
-
Eliquis is used to treat the following conditions:
- Deep Vein Thrombosis
- Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery
- Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery
- Deep Vein Thrombosis, Prophylaxis
- Prevention of Thromboembolism in Atrial Fibrillation
- Pulmonary Embolism
- Thromboembolic Stroke Prophylaxis
- Venous Thromboembolism
polyethylene glycol 3350 with electrolytes
A total of 396 drugs are known to interact with polyethylene glycol 3350 with electrolytes.
- Polyethylene glycol 3350 with electrolytes is in the drug class laxatives.
- Polyethylene glycol 3350 with electrolytes is used to treat the following conditions:
Drug and food interactions
polyethylene glycol 3350 with electrolytes food
Applies to: polyethylene glycol 3350 with electrolytes
ADJUST DOSING INTERVAL: Bowel cleansing products can increase the gastrointestinal transit rate. Oral medications administered within one hour of the start of administration of the bowel cleansing solution may be flushed from the gastrointestinal tract and not properly absorbed.
MANAGEMENT: Patients should be advised that absorption of oral medications may be impaired during bowel cleansing treatment. Oral medications (e.g., anticonvulsants, oral contraceptives, antidiabetic agents, antibiotics) should not be administered during and within one hour of starting bowel cleansing treatment whenever possible. However, if concomitant use cannot be avoided, monitoring for reduced therapeutic effects may be advisable.
References (2)
- "Product Information. Golytely (polyethylene glycol 3350 with electrolytes)." Braintree
- (2022) "Product Information. Prepopik (citric acid/Mg oxide/Na picosulfate)." Ferring Pharmaceuticals Inc
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.